Key facts
- Arena Labs’s last known valuation is $18.3M (Feb 2025).
- It has raised $3.3M across 1 recorded rounds; the latest was Seed Round ($3.3M) in Mar 2024.
- Notable investors include Capital Factory, InvestTN, Rsquared, Scout Ventures, Locke Capital — 6 tracked in total.
- Arena Labs has filed 1 Form D with the SEC, most recently Apr 2024 ($3.3M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Arena Labs
Funding rounds
1 roundsAbout Arena Labs
Developer of a performance coaching platform designed for training healthcare professionals. The company's platform offers personalized analytics and feedback on clinician health and performance, data-driven methodologies, actionable daily practices and coaching that optimize stress, energy, and recovery management, and data insights that track changes and measure progress in clinicians' biomarkers, enabling frontline clinicians to prepare for, respond to, and recover from the chronic pressure of living on the frontlines of healthcare.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2016
- Employees
- 30
- Website
- arenalabs.co/
- Ownership
- Privately Held (backing)
Arena Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arena Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arena Labs in its N-PORT filings yet. We sweep new filings monthly.